Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review. [PDF]
Bertozzi S +8 more
europepmc +1 more source
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation. [PDF]
Fujii T +13 more
europepmc +1 more source
Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers. [PDF]
Paolino G +7 more
europepmc +1 more source
BRCA mutation and multiple primary malignancies: a rare case of recurring triple-negative breast cancer and cervical cancer. [PDF]
Naciri M +6 more
europepmc +1 more source
Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation. [PDF]
Lian QX, Song Y, Han L, Wang Z, Song Y.
europepmc +1 more source
Interpreting pathways to discover cancer driver genes with Moonlight [PDF]
al., et +2 more
core +1 more source
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation. [PDF]
Saad F +8 more
europepmc +1 more source
Satisfaction and Well-Being After Contralateral Prophylactic Mastectomy Among BRCA Mutation Carriers and Noncarriers: A Longitudinal Analysis of BREAST-Q Domains. [PDF]
Myers SP +7 more
europepmc +1 more source
Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome [PDF]
't Kint de Roodenbeke, Daphné +10 more
core
BRCA Mutation Testing in Men With Metastatic Castration-Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice. [PDF]
Azad AA +4 more
europepmc +1 more source

